Some news from Benzinga presentation. One is it appears that the company expects the peer review to be out at any time now. He said that multiple times during the call and was extremely excited about the detail that has gone into the report. Perhaps we see a presentation at CTAD in November but that wasn't asked. Sounds like review will be published before that.
FragileX should begin enrollment around the end of the year or first of 2022. Working hard with the FDA to get it kicked off. Said MS collaborator will be announced soon and expect trial to kick off in similar time frame. Announced that a 3rd, yet to be named trial, will be announced near term as well. I don't have a guess as to what that will be at this time.
Market Data 
Markets 
AI
